A Henderson man has been hauled into court after being accused of smuggling and selling misbranded erectile dysfunction drugs. David Ralph Webber made his initial appearance on September 10, facing multiple charges related to the illegal distribution of drugs containing the active ingredients found in Viagra and Cialis.
The indictment, which came down from a federal grand jury on July 30, includes a count of introduction of a misbranded drug into interstate commerce, four counts of distributing prescription drugs without a license, and seven counts of smuggling. Webber, who is not registered with the FDA nor licensed to distribute prescription drugs, allegedly got his supply from manufacturers in India, peddling them under cheeky names like "Kinky Kong," "Stif," and "Ride," to name a few.
According to a statement from the FDA’s Office of Criminal Investigations, these off-brand ED pills were sold not just online but through various retail outlets including smoke shops and adult novelty stores. The indictment highlights concerns over the potential health risks posed to individuals on heart or blood-thinning medications if such drugs are not properly prescribed.
Claiming the products were “100% Natural” and over-the-counter, Webber allegedly misled consumers with falsely labeled ingredients and unfounded assertions. These actions not only flout FDA regulations but potentially endanger public health, a point underscored by FDA Special Agent in Charge Robert M. Iwanicki who remarked, "Americans depend on the FDA to ensure that drugs are safe and accurately labeled," as reported by the Department of Justice. His overall message was clear: regulatory bypasses that put consumers at risk will not be overlooked.
Webber's trial is slated for November 18, 2025, before United States District Judge Jennifer A. Dorsey. The court case gathers steam amidst broad enforcement efforts to clamp down on illegal pharmaceutical operations. Acting United States Attorney Sigal Chattah for the District of Nevada and Special Agent in Charge Iwanicki jointly announced the indictment yesterday. The investigation was a cooperative endeavor between the FDA and the United States Postal Inspection Service, with Assistant United States Attorney Jean Ripley spearheading the prosecution.
The authorities have also reached out to the public for aid. Individuals who have taken these products or who have suffered adverse health effects are being asked to contact investigators via the FDA website link provided in the announcement. It is crucial to note that an indictment is merely an accusation, and the defendant is presumed innocent unless proven guilty in a court of law.
